Anesthesiology and Pain Medicine

Published by: Kowsar

Flow Cytometry of CD64, HLA-DR, CD25, and TLRs for Diagnosis and Prognosis of Sepsis in Critically Ill Patients Admitted to the Intensive Care Unit: A Review Article

Ata Mahmoodpoor 1 , Seyedpouya Paknezhad 2 , Kamran Shadvar 1 , Hadi Hamishehkar 3 , Ali Akbar Movassaghpour 4 , Sarvin Sanaie 5 , Ali Akbar Ghamari 1 and Hassan Soleimanpour 2 , *
Authors Information
1 Anesthesiology Research Team, Tabriz University of Medical Sciences, Tabriz, Iran
2 Emergency Medicine Research Team, Tabriz University of Medical Sciences, Tabriz, Iran
3 Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
4 Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
5 Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran
Article information
  • Anesthesiology and Pain Medicine: December 31, 2018, 8 (6); e83128
  • Published Online: December 5, 2018
  • Article Type: Review Article
  • Received: August 10, 2018
  • Revised: October 24, 2018
  • Accepted: November 15, 2018
  • DOI: 10.5812/aapm.83128

To Cite: Mahmoodpoor A, Paknezhad S , Shadvar K, Hamishehkar H, Movassaghpour A A , et al. Flow Cytometry of CD64, HLA-DR, CD25, and TLRs for Diagnosis and Prognosis of Sepsis in Critically Ill Patients Admitted to the Intensive Care Unit: A Review Article, Anesth Pain Med. 2018 ; 8(6):e83128. doi: 10.5812/aapm.83128.

Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
  • 1. Monneret G, Venet F, Pachot A, Lepape A. Monitoring immune dysfunctions in the septic patient: A new skin for the old ceremony. Mol Med. 2008;14(1-2):64-78. doi: 10.2119/2007-00102.Monneret. [PubMed: 18026569]. [PubMed Central: PMC2078557].
  • 2. Warren HS. Strategies for the treatment of sepsis. N Engl J Med. 1997;336(13):952-3. doi: 10.1056/NEJM199703273361311. [PubMed: 9070479].
  • 3. Brunkhorst FM. [Epidemiology, economy and practice - results of the German study on prevalence by the competence network sepsis (SepNet)]. Anasthesiol Intensivmed Notfallmed Schmerzther. 2006;41(1):43-4. German. doi: 10.1055/s-2005-921227. [PubMed: 16440262].
  • 4. Scerbo MH, Kaplan HB, Dua A, Litwin DB, Ambrose CG, Moore LJ, et al. Beyond blood culture and gram stain analysis: A review of molecular techniques for the early detection of bacteremia in surgical patients. Surg Infect (Larchmt). 2016;17(3):294-302. doi: 10.1089/sur.2015.099. [PubMed: 26918696]. [PubMed Central: PMC5118953].
  • 5. Liu Y, Hou JH, Li Q, Chen KJ, Wang SN, Wang JM. Biomarkers for diagnosis of sepsis in patients with systemic inflammatory response syndrome: A systematic review and meta-analysis. Springerplus. 2016;5(1):2091. doi: 10.1186/s40064-016-3591-5. [PubMed: 28028489]. [PubMed Central: PMC5153391].
  • 6. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31(4):1250-6. doi: 10.1097/01.CCM.0000050454.01978.3B. [PubMed: 12682500].
  • 7. [No authors listed]. For sepsis, the drugs don't work. Lancet Infect Dis. 2012;12(2):89. doi: 10.1016/S1473-3099(12)70020-8. [PubMed: 22281132].
  • 8. Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: A novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis. 2013;13(3):260-8. doi: 10.1016/S1473-3099(13)70001-X.
  • 9. Gentile LF, Cuenca AG, Efron PA, Ang D, Bihorac A, McKinley BA, et al. Persistent inflammation and immunosuppression: A common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg. 2012;72(6):1491-501. doi: 10.1097/TA.0b013e318256e000. [PubMed: 22695412]. [PubMed Central: PMC3705923].
  • 10. Vanzant EL, Lopez CM, Ozrazgat-Baslanti T, Ungaro R, Davis R, Cuenca AG, et al. Persistent inflammation, immunosuppression, and catabolism syndrome after severe blunt trauma. J Trauma Acute Care Surg. 2014;76(1):21-9. discussion 29-30. doi: 10.1097/TA.0b013e3182ab1ab5. [PubMed: 24368353]. [PubMed Central: PMC4310749].
  • 11. Tang D, Kang R, Coyne CB, Zeh HJ, Lotze MT. PAMPs and DAMPs: Signal 0s that spur autophagy and immunity. Immunol Rev. 2012;249(1):158-75. doi: 10.1111/j.1600-065X.2012.01146.x. [PubMed: 22889221]. [PubMed Central: PMC3662247].
  • 12. Rubartelli A, Lotze MT. Inside, outside, upside down: Damage-associated molecular-pattern molecules (DAMPs) and redox. Trends Immunol. 2007;28(10):429-36. doi: 10.1016/ [PubMed: 17845865].
  • 13. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-10. doi: 10.1001/jama.2016.0287. [PubMed: 26903338]. [PubMed Central: PMC4968574].
  • 14. Givan AL. Flow cytometry: An introduction. Methods Mol Biol. 2011;699:1-29. doi: 10.1007/978-1-61737-950-5_1. [PubMed: 21116976].
  • 15. Venet F, Lepape A, Monneret G. Clinical review: Flow cytometry perspectives in the ICU - from diagnosis of infection to monitoring of injury-induced immune dysfunctions. Crit Care. 2011;15(5):231. doi: 10.1186/cc10333. [PubMed: 22017882]. [PubMed Central: PMC3334725].
  • 16. Cid J, Aguinaco R, Sanchez R, Garcia-Pardo G, Llorente A. Neutrophil CD64 expression as marker of bacterial infection: A systematic review and meta-analysis. J Infect. 2010;60(5):313-9. doi: 10.1016/j.jinf.2010.02.013. [PubMed: 20206205].
  • 17. Wang X, Li ZY, Zeng L, Zhang AQ, Pan W, Gu W, et al. Neutrophil CD64 expression as a diagnostic marker for sepsis in adult patients: a meta-analysis. Crit Care. 2015;19:245. doi: 10.1186/s13054-015-0972-z. [PubMed: 26059345]. [PubMed Central: PMC4490738].
  • 18. Bauer PR, Kashyap R, League SC, Park JG, Block DR, Baumann NA, et al. Diagnostic accuracy and clinical relevance of an inflammatory biomarker panel for sepsis in adult critically ill patients. Diagn Microbiol Infect Dis. 2016;84(2):175-80. doi: 10.1016/j.diagmicrobio.2015.10.003. [PubMed: 26586579]. [PubMed Central: PMC4716883].
  • 19. Bae MH, Park SH, Park CJ, Cho EJ, Lee BR, Kim YJ, et al. Flow cytometric measurement of respiratory burst activity and surface expression of neutrophils for septic patient prognosis. Cytometry B Clin Cytom. 2016;90(4):368-75. doi: 10.1002/cyto.b.21274. [PubMed: 26202936].
  • 20. Coberly J, Johnson C, Hammer R. Neutrophil CD64 by flow cytometry has excellent negative predictive value for excluding sepsis. Am J Clin Pathol. 2015;144(suppl_2):A144. doi: 10.1093/ajcp/144.suppl2.144.
  • 21. Muzlovic I, Ihan A, Stubljar D. CD64 index on neutrophils can diagnose sepsis and predict 30-day survival in subjects after ventilator-associated pneumonia. J Infect Dev Ctries. 2016;10(3):260-8. doi: 10.3855/jidc.6532. [PubMed: 27031458].
  • 22. Winkler MS, Rissiek A, Priefler M, Schwedhelm E, Robbe L, Bauer A, et al. Human leucocyte antigen (HLA-DR) gene expression is reduced in sepsis and correlates with impaired TNFalpha response: A diagnostic tool for immunosuppression? PLoS One. 2017;12(8). e0182427. doi: 10.1371/journal.pone.0182427. [PubMed: 28771573]. [PubMed Central: PMC5542660].
  • 23. Lekkou A, Karakantza M, Mouzaki A, Kalfarentzos F, Gogos CA. Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections. Clin Diagn Lab Immunol. 2004;11(1):161-7. [PubMed: 14715564]. [PubMed Central: PMC321326].
  • 24. Zouiouich M, Gossez M, Venet F, Rimmele T, Monneret G. Automated bedside flow cytometer for mHLA-DR expression measurement: A comparison study with reference protocol. Intensive Care Med Exp. 2017;5(1):39. doi: 10.1186/s40635-017-0156-z. [PubMed: 28856633]. [PubMed Central: PMC5577346].
  • 25. Llewelyn MJ, Berger M, Gregory M, Ramaiah R, Taylor AL, Curdt I, et al. Sepsis biomarkers in unselected patients on admission to intensive or high-dependency care. Crit Care. 2013;17(2):R60. doi: 10.1186/cc12588. [PubMed: 23531337]. [PubMed Central: PMC3672658].
  • 26. Matera G, Puccio R, Giancotti A, Quirino A, Pulicari MC, Zicca E, et al. Impact of interleukin-10, soluble CD25 and interferon-gamma on the prognosis and early diagnosis of bacteremic systemic inflammatory response syndrome: A prospective observational study. Crit Care. 2013;17(2):R64. doi: 10.1186/cc12596. [PubMed: 23561467]. [PubMed Central: PMC4056318].
  • 27. Garcia de Guadiana-Romualdo L, Berger M, Jimenez-Santos E, Rebollo-Acebes S, Jimenez-Sanchez R, Esteban-Torrella P, et al. Pancreatic stone protein and soluble CD25 for infection and sepsis in an emergency department. Eur J Clin Invest. 2017;47(4):297-304. doi: 10.1111/eci.12732. [PubMed: 28155994].
  • 28. Monneret G, Debard AL, Venet F, Bohe J, Hequet O, Bienvenu J, et al. Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis. Crit Care Med. 2003;31(7):2068-71. doi: 10.1097/01.CCM.0000069345.78884.0F. [PubMed: 12847405].
  • 29. Chen Q, Shi J, Fei A, Wang F, Pan S, Wang W. Neutrophil CD64 expression is a predictor of mortality for patients in the intensive care unit. Int J Clin Exp Pathol. 2014;7(11):7806-13. [PubMed: 25550820]. [PubMed Central: PMC4270525].
  • 30. Djordjevic D, Pejovic J, Surbatovic M, Jevdjic J, Radakovic S, Veljovic M, et al. Prognostic value and daily trend of interleukin-6, neutrophil CD64 expression, C-reactive protein and lipopolysaccharide-binding protein in critically ill patients: Reliable predictors of outcome or not? J Med Biochem. 2015;34(4):431-9. doi: 10.1515/jomb-2015-0002. [PubMed: 28356852]. [PubMed Central: PMC4922357].
  • 31. Skirecki T, Mikaszewska-Sokolewicz M, Hoser G, Zielinska-Borkowska U. The early expression of HLA-DR and CD64 myeloid markers is specifically compartmentalized in the blood and lungs of patients with septic shock. Mediators Inflamm. 2016;2016:3074902. doi: 10.1155/2016/3074902. [PubMed: 27413252]. [PubMed Central: PMC4930815].
  • 32. Dai J, Jiang W, Min Z, Yang J, Tan Y, Ma T, et al. Neutrophil CD64 as a diagnostic marker for neonatal sepsis: Meta-analysis. Adv Clin Exp Med. 2017;26(2):327-32. doi: 10.17219/acem/58782. [PubMed: 28791853].
  • 33. Danikas DD, Karakantza M, Theodorou GL, Sakellaropoulos GC, Gogos CA. Prognostic value of phagocytic activity of neutrophils and monocytes in sepsis. Correlation to CD64 and CD14 antigen expression. Clin Exp Immunol. 2008;154(1):87-97. doi: 10.1111/j.1365-2249.2008.03737.x. [PubMed: 18727624]. [PubMed Central: PMC2561092].
  • 34. Pfortmueller CA, Meisel C, Fux M, Schefold JC. Assessment of immune organ dysfunction in critical illness: Utility of innate immune response markers. Intensive Care Med Exp. 2017;5(1):49. doi: 10.1186/s40635-017-0163-0. [PubMed: 29063386]. [PubMed Central: PMC5653680].
  • 35. Reinke P, Volk HD. Diagnostic and predictive value of an immune monitoring program for complications after kidney transplantation. Urol Int. 1992;49(2):69-75. doi: 10.1159/000282398. [PubMed: 1441015].
  • 36. Polk HC Jr, George CD, Wellhausen SR, Cost K, Davidson PR, Regan MP, et al. A systematic study of host defense processes in badly injured patients. Ann Surg. 1986;204(3):282-99. [PubMed: 3019260]. [PubMed Central: PMC1251278].
  • 37. Cheron A, Floccard B, Allaouchiche B, Guignant C, Poitevin F, Malcus C, et al. Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma. Crit Care. 2010;14(6):R208. doi: 10.1186/cc9331. [PubMed: 21092108]. [PubMed Central: PMC3220028].
  • 38. Lukaszewicz AC, Grienay M, Resche-Rigon M, Pirracchio R, Faivre V, Boval B, et al. Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction. Crit Care Med. 2009;37(10):2746-52. doi: 10.1097/CCM.0b013e3181ab858a. [PubMed: 19707128].
  • 39. Monneret G, Venet F. Monocyte HLA-DR in sepsis: Shall we stop following the flow? Crit Care. 2014;18(1):102. doi: 10.1186/cc13179. [PubMed: 24393356]. [PubMed Central: PMC4056426].
  • 40. Saito K, Wagatsuma T, Toyama H, Ejima Y, Hoshi K, Shibusawa M, et al. Sepsis is characterized by the increases in percentages of circulating CD4+CD25+ regulatory T cells and plasma levels of soluble CD25. Tohoku J Exp Med. 2008;216(1):61-8. [PubMed: 18719339].
  • 41. Holst B, Szakmany T, Raby AC, Hamlyn V, Durno K, Hall JE, et al. Soluble Toll-like receptor 2 is a biomarker for sepsis in critically ill patients with multi-organ failure within 12 h of ICU admission. Intensive Care Med Exp. 2017;5(1):2. doi: 10.1186/s40635-016-0116-z. [PubMed: 28092080]. [PubMed Central: PMC5236041].
  • 42. Savva A, Roger T. Targeting toll-like receptors: Promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases. Front Immunol. 2013;4:387. doi: 10.3389/fimmu.2013.00387.
  • 43. Souza-Fonseca-Guimaraes F, Parlato M, Philippart F, Misset B, Cavaillon JM, Adib-Conquy M, et al. Toll-like receptors expression and interferon-gamma production by NK cells in human sepsis. Crit Care. 2012;16(5):R206. doi: 10.1186/cc11838. [PubMed: 23098236]. [PubMed Central: PMC3682310].
  • 44. Osrin D, Vergnano S, Costello A. Serious bacterial infections in newborn infants in developing countries. Curr Opin Infect Dis. 2004;17(3):217-24. [PubMed: 15166824].
  • 45. Janjindamai W, Phetpisal S. Time to positivity of blood culture in newborn infants. Southeast Asian J Trop Med Public Hlth. 2006;37(1):171-6. [PubMed: 16771231].
  • 46. Shi J, Tang J, Chen D. Meta-analysis of diagnostic accuracy of neutrophil CD64 for neonatal sepsis. Ital J Pediatr. 2016;42(1):57. doi: 10.1186/s13052-016-0268-1. [PubMed: 27268050]. [PubMed Central: PMC4897921].
  • 47. Kanakoudi-Tsakalidou F, Debonera F, Drossou-Agakidou V, Sarafidis K, Tzimouli V, Taparkou A, et al. Flow cytometric measurement of HLA-DR expression on circulating monocytes in healthy and sick neonates using monocyte negative selection. Clin Exp Immunol. 2001;123(3):402-7. [PubMed: 11298126]. [PubMed Central: PMC1906016].
  • 48. Ng PC, Li G, Chui KM, Chu WC, Li K, Wong RP, et al. Quantitative measurement of monocyte HLA-DR expression in the identification of early-onset neonatal infection. Biol Neonate. 2006;89(2):75-81. doi: 10.1159/000088288. [PubMed: 16158006].
  • 49. Genel F, Atlihan F, Ozsu E, Ozbek E. Monocyte HLA-DR expression as predictor of poor outcome in neonates with late onset neonatal sepsis. J Infect. 2010;60(3):224-8. doi: 10.1016/j.jinf.2009.12.004. [PubMed: 20025903].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments